目次

Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter- 2: Summary and Highlights
Market Size and Evolution

Chapter- 3: Market Overview
Introduction
Recent History of the Generic Drug Industry

Chapter- 4: Impact of COVID-19
Overview
Impact of COVID-19 on the Market for Generic Drugs

Chapter- 5: The New Generics Era
Overview
The Patent Cliff
Types of Generic Drugs
ANDA (Abbreviated New Drug Application) Approvals

Chapter- 6: Major Issues Within the Market for Generic Drugs
Regulatory Environment
Regulation of Biosimilars
Defensive Strategies Used by Big Pharma
Authorized Generic Drugs
Patents and IP

Chapter- 7: Global Market for Generic Drugs
Global Pharmaceutical Market: Brand Name and Generic Drugs
Global Market for Generic Drugs

Chapter- 8: Market Breakdown by Region
Introduction
North America
Asia-Pacific
Europe
Rest of the World

Chapter- 9: Industry Trends
Competitive Landscape
Market Trends
Structure of the Generic Drug Industry
Recent Mergers and Acquisitions
Brand Name Company Involvement

Chapter- 10: Company Profiles
ASPEN HOLDINGS
CIPLA INC.
FRESENIUS KABI
LUPIN LTD.
MYLAN INC.
PFIZER INC.
SANDOZ INTERNATIONAL GMBH
SANOFI
SUN PHARMACEUTICAL INDUSTRIES LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Chapter- 11: Other International Companies
AUROBINDO PHARMA LTD.
DR. REDDY'S LABORATORIES LTD.
EGIS PHARMACEUTICALS PLC
KRKA
PAR PHARMACEUTICAL INC.
STADA ARZNEIMITTEL
STRIDES SHASUN LTD.
WOCKHARDT LTD.
ZYDUS CADILA

Chapter- 12: Appendix: Terminology and Acronyms
Table 38 : Acronyms Used in This Report